GFN•TV will bring the conference's platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction to an audience all year round. GFN•TV will also be broadcasting live from Warsaw in June. Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments. From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.
GFN.TV Interviews | HARDLY FREE | U.S. Vape Advocacy in Post “Epidemic” Era
While the United States of America is ground zero for the anti-vaping propaganda and misinformation that poisoned worldwide public perception of vaping, it’s also home to a solid and relentless vaping advocacy community pushing back against the anti-vaping hordes. How are they doing? Find out in this episode of GFN Interviews.
GFN.TV Interviews | DE-DEMONIZING NICOTINE | Ending Fear to Promote Benefits
According to harm reduction consultant and developmental neurobiologist Charles Gardner, there's a particular piece of information you are not supposed to talk about, promote nor expect public health to acknowledge. What is it? That nicotine is not carcinogenic and, when consumed outside of a cigarette, is relatively benign. Gardner considers it likely that nicotine is no more harmful than caffeine - and in his opinion, it could have significant health benefits. Gardner believes it's time to 'de-demonize nicotine'.
Featuring: Charles A. Gardner, PhD Consultant, Harm Reduction Strategies Developmental Neurobiologist @ChaunceyGardner
GFN.TV Interviews | DISPARATE SCIENCE | Top Researcher Says E-Cigs Are Game Changer
There is too much emotion driving public policy on e-cigarettes, says leading tobacco control researcher Dr. Jasjit Ahluwalia. A physician, public health scientist, and professor at Brown University’s Schools of Public Health and Medicine, Dr. Ahluwalia has deep experience researching health disparities and smoking cessation and nicotine addiction in African-American smokers. He has been continuously funded by the NIH for 25 years and has published over 400 manuscripts. Hear his assessment on the efficacy and relative safety of e-cigarettes and other safer nicotine products.
Featuring: Dr. Jasjit Ahluwalia, Physician, Public Health Scientist Prof. Behavioral and Social Sciences & Internal Medicine Center for Alcohol & Addiction Studies, Brown University School of Public Health (@Brown_SPH)
📅 15 Sep 2023
GFN.TV Interviews | NO SYMPATHY | How Tobacco Control Ignores People They Purport to Help
Tobacco control has no sympathy for the smoker, says Samrat Chowdhery tobacco harm reduction expert and consumer activist. He says there has to be a more humane way to tackle the tobacco problem and tobacco control needs to start thinking more like drugs control.
GFN.TV Interviews | SAVING CHALO | THR Education on The Big Screen
Tobacco harm reduction activist and award-winning African filmmaker discusses unheard narratives around safer nicotine products, smoking cessation, and tobacco control.
Featuring: Emmanuel Mwape Award Winning Filmmaker, THR Activist K•A•C Global THR Scholar, Zambia @mwape_emmanuel
📅 18 Aug 2023
GFN.TV Interviews | BASELINE | Discovering the Similarities Between Tobacco and Drug Harm Reduction
Editor and co-founder of Drink and Drugs News discusses the difficulties of tackling smoking and how many people working in the drug harm reduction field don’t see it as a problem.
Featuring: Claire Brown Editor & Co-founder, Drink and Drugs News Magazine drinkanddrugsnews.com @DDNMagazine
📅 4 Aug 2023
GFN.TV Interviews | IMPERVIOUS TO EVIDENCE | Tobacco Control Blocks Vaping Debate in Australia
There’s no debate allowed on vaping in Australia, says Dr. Colin Mendelsohn, founding chairman of the Australian Tobacco Harm Reduction Association and practicing tobacco treatment specialist. Tobacco control is “impervious to evidence” and quick to cancel anyone who speaks to the positives of vaping.
Featuring: Dr Colin Mendelsohn Founding Chairman Australian Tobacco Harm Reduction Association Practising Tobacco Treatment Specialist @colinmendelsohn
📅 21 Jul 2023
GFN.TV Interviews | MICHAEL RUSSELL AWARD | Honouring A Lifetime’s Commitment to Evidence-Based Public Health
Professor Gerry Stimson, public health social scientist and co-founder of the Global Forum on Nicotine receives the 2023 Michael Russell Award in recognition of a lifetime’s commitment to evidence-based public health interventions. Hear his reaction to the award and thoughts about what’s coming next for GFN and tobacco harm reduction.
Featuring: Gerry Stimson Co-founder, Global Forum on Nicotine Director, Knowledge-Action-Change (KAC) Emeritus Professor Imperial College London @GFNicotine
📅 7 Jul 2023
GFN.TV Interviews | BETTER TOMORROW | BAT & The Science for Tobacco Harm Reduction
Hear how science drives the development of reduced-risk nicotine products at BAT, one of the world’s largest tobacco companies. And learn how it uses science to help ‘seal the deal’ with regulators.
Featuring: DR. Summer Hanna VP Scientific Regulatory Engagement, BAT bat-science.com
📅 16 Jun 2023
GFN.TV Interviews | ‘PATIENT’ CONTROL | Clive Bates Previews GFN 2023 & The Big THR Conversation
Could tobacco control be facing impending irrelevance? It may be the case considering safer nicotine products solve a problem many have spent entire careers trying to fix through blunt force and turning smokers into patients.
Featuring: Clive Bates Tobacco Control Policy Expert, Counterfactual Consulting Former Dir. of Action on Smoking and Health (UK) @Clive_Bates clivebates.com
